Andreas Kluge
Fondateur chez TELIX PHARMACEUTICALS LIMITED
Fortune : 274 M $ au 31/05/2024
Profil
Andreas Kluge founded Telix Pharmaceuticals Ltd.
in 2015, where he is working as Non-Executive Director from 2020, Therapeia GmbH & Co. Kg in 2007, where he is working as Chief Executive Officer from 2007, ABX-CRO advanced pharmaceutical services in 2002, where he is working as General Manager & Medical Director from 2002, and ABX advanced biochemical compounds GmbH in 1996, where he worked as Chief Executive Officer from 1996 to 2002.
Dr. Kluge received his doctorate degree from Freie Universität Berlin.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
24/01/2024 | 22 675 000 ( 6,79% ) | 274 M $ | 31/05/2024 |
Postes actifs de Andreas Kluge
Sociétés | Poste | Début |
---|---|---|
TELIX PHARMACEUTICALS LIMITED | Fondateur | 01/11/2015 |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Directeur Général | 01/01/2007 |
ABX-CRO advanced pharmaceutical services | Fondateur | 01/08/2002 |
Anciens postes connus de Andreas Kluge
Sociétés | Poste | Fin |
---|---|---|
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Directeur Général | 01/07/2002 |
Formation de Andreas Kluge
Freie Universität Berlin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
TELIX PHARMACEUTICALS LIMITED | Health Technology |
Entreprise privées | 3 |
---|---|
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Process Industries |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Health Technology |
ABX-CRO advanced pharmaceutical services |